findmyKOL

Crystal Tyson, MD

Basic profile

Duke University

ORCID↗NPI↗
✓ Full record
RegionDurham, NC · SoutheastSpecialtyNephrologyFocusNephrology
Active KOLfindmyKOL type: NationalLatest publication2024Online presenceNot yet checkedPaymentsNone reportedNIH funding2019–2026Why? →

Crystal Tyson is a Nephrology physician affiliated with Duke University. OpenAlex indexes 72 publications with 2,812 citations (h-index 23); ClinicalTrials.gov lists 4 registered studies matched to this name.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
72publications

Distinct works indexed by OpenAlex, matched via ORCID.

2,812citations

Total citations across indexed works.

23h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
4clinical trials

Investigator role on registered studies.

View trials ↓
3NIH grants · 2019–2026

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Duke University Medcial Ctr
Durham, NC 277100001

Telephone

919-660-6626

Registry record last updated 1 May 2013.

View the NPPES registry record

Clinical trials

All 4 trial records: search, sort and filter.Explore →

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    77.3%
    Calcium channel blocker17.1%
    Amlodipine Besylate100%
    Part D≥17 patients
    Beta blocker14.5%
    Carvedilol39%Metoprolol Succinate34%Labetalol Hcl27%
    Part D<11 patients

    + 6 more classes in this area

  • Metabolism & gastrointestinal

    22.7%
    SGLT2 inhibitor17.1%
    Farxiga46%Jardiance31%Invokana23%
    Part D<11 patients
    Potassium supplement5.6%
    Potassium Chloride100%
    Part D<11 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

3 NIH research awards on record, funded 2019–2026 per NIH RePORTER. The latest:

All 8 award records: search, sort and filter.Explore →

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

All 50 publications: search, sort and filter.Explore →

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”